Transdermal scopolamine to reduce salivation and possibly aspiration after stroke.
We report two cases illustrating a potential use of transdermal scopolamine to reduce salivation in acute stroke. We speculate that this may lead to reduced aspiration and possibly also less pneumonia. However, the treatment is associated with side effects. Finally, we suggest that this use of transdermal scopolamine in stroke may be a topic for a randomized clinical trial.
Rønning
Ole Morten
OM
Stroke Unit, Department of Neurology, Akershus University Hospital, Lørenskog, Norway. ole.morten.running@ahus.no
Stavem
Knut
K